{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Hagen AN"],"funding":["Northern Norway Health Authority"],"pagination":["oeac061"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9583183"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["2(5)"],"pubmed_abstract":["<h4>Aims</h4>To study change over 8 years in cardiovascular risk, achievement of national guideline-based treatment targets of lipids, blood pressure (BP) and smoking in primary prevention of cardiovascular disease (CVD), medication use, and characteristics associated with target achievement among individuals with high CVD risk in a general population.<h4>Methods and results</h4>We followed 2524 women and men aged 40-79 years with high risk of CVD attending the population-based Tromsø study in 2007-08 (Tromsø6) to their participation in the next survey in 2015-16 (Tromsø7). We used descriptive statistics and regression models to study change in CVD risk and medication use, and characteristics associated with treatment target achievement. In total, 71.4% reported use of BP- and/or lipid-low"],"journal":["European heart journal open"],"pubmed_title":["Achievements of primary prevention targets in individuals with high risk of cardiovascular disease: an 8-year follow-up of the Tromso study."],"pmcid":["PMC9583183"],"funding_grant_id":["HNF1363-17"],"pubmed_authors":["Hagen AN","Ariansen I","Eggen AE","Njolstad I","Lappegard KT","Wilsgaard T","Lochen ML","Hopstock LA","Hanssen TA"],"additional_accession":[]},"is_claimable":false,"name":"Achievements of primary prevention targets in individuals with high risk of cardiovascular disease: an 8-year follow-up of the Tromso study.","description":"<h4>Aims</h4>To study change over 8 years in cardiovascular risk, achievement of national guideline-based treatment targets of lipids, blood pressure (BP) and smoking in primary prevention of cardiovascular disease (CVD), medication use, and characteristics associated with target achievement among individuals with high CVD risk in a general population.<h4>Methods and results</h4>We followed 2524 women and men aged 40-79 years with high risk of CVD attending the population-based Tromsø study in 2007-08 (Tromsø6) to their participation in the next survey in 2015-16 (Tromsø7). We used descriptive statistics and regression models to study change in CVD risk and medication use, and characteristics associated with treatment target achievement. In total, 71.4% reported use of BP- and/or lipid-low","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2026-06-20T03:21:41.814Z","creation":"2024-11-10T06:37:29.268Z"},"accession":"S-EPMC9583183","cross_references":{"pubmed":["36284643"],"doi":["10.1093/ehjopen/oeac061"]}}